NCT02035696 - Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old | Biotech Hunter

Enrollment

671

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions

Influenza

Interventions

BIOLOGICAL

Trivalent influenza vaccine (TIVc)

BIOLOGICAL

Trivalent influenza vaccine-licensed

Licensed influenza vaccine

Trial Locations (27)

Site 116, Phoenix

Site 119, Tucson

Site 109, Little Rock

Site 112, Long Beach

Site 113, Ontario

Site 117, San Diego

Site 114, West Covina

Site 107, Thornton

Site 111, Miami

Site 108, Miami Beach

Site 121, Gainesville

Site 101, Omaha

Site 104, Omaha

Site 105, Omaha

Site 106, Omaha

Site 103, Youngstown

Site 102, Charleston

Site 115, Houston

Site 110, Salt Lake City

Site 118, St. George

Site 120, Spokane

Site 502, Kuopio

Site 506, Tampere

Site 302, City of Muntinlupa

Site 301, Manila

Site 201, Bangkok

Site 202, Bangkok